Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets-Reference-Cited by-同舟云学术

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

Published:2010-01-18 Issue:14 Volume:29 Page:2013-2023
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Turner N,Lambros M B,Horlings H M,Pearson A,Sharpe R,Natrajan R,Geyer F C,van Kouwenhove M,Kreike B,Mackay A,Ashworth A,van de Vijver M J,Reis-Filho J S

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2009489.pdf

Reference47 articles.

1. Adelaide J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F et al. (2007). Integrated profiling of basal and luminal breast cancers. Cancer Res 67: 11565–11575.

2. Agrawal G, Chen JH, Baick CH, Chen AE, Mehta RS, Nalcioglu O et al. (2007). Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy. J Clin Oncol 25: 2618–2620.

3. Andre F, Job B, Dessen P, Tordai A, Michiels S, Liedtke C et al. (2009). Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin Cancer Res 15: 441–451.

4. Benjamini Y, Hochberg Y . (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc 57: 289–300.

5. Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V et al. (2008). Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res 68: 7165–7175.

Cited by 346 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple-Negative Breast Cancer: Molecular Particularities Still a Challenge;Diagnostics;2024-08-27

2. Obtention of viable cell suspensions from breast cancer tumor biopsies for 3D chromatin conformation and single-cell transcriptome analysis;Frontiers in Molecular Biosciences;2024-08-22

3. Fibroblast growth factor receptor signaling in estrogen receptor-positive breast cancer: mechanisms and role in endocrine resistance;Frontiers in Oncology;2024-07-08

4. Clinical Efficacy and Mechanism of Action of Recently FDA Approved Anticancer Drugs: An Updated Review;Current Cancer Therapy Reviews;2024-04-09

5. Is fibroblast growth factor 11 (FGF11) a predictive marker for breast cancer?;Medicine;2024-03-29